Speaker illustration

Professor Madeleine Cunningham

University of Oklahoma Health Sciences Center, Oklahoma City (United States of America)

Member of:

European Society of Cardiology

Dr Cunningham’s research has been funded by the American Heart Assn and NHLBI to study rheumatic heart disease, myocarditis, cardiomyopathy and heart failure. Her studies have pioneered work in understanding how infections and autoimmunity lead to disease in the heart. Her laboratory has focused on human translational research and defining inflammatory and autoimmune mechanisms in the heart in rheumatic carditis, myocarditis, cardiomyopathy and heart failure to understand disease pathogenesis and define biomarkers of poor outcomes and inform about therapeutic options. Dr. Cunningham has served many years on study sections and review committees at the National Institutes of Health, American Heart Association (AHA), Veterans Administration USA, and she served 5 years on the AHA National Research Committee. She was a representative of the United States for the US-Indo Vaccine Action Program. She was elected an AAAS and ASM fellow. Dr Cunningham is the author of 150+ publications.

Th17 signature, autoimmunity and differentially expressed genes in cardiomyopathy and heart failure

Event: ESC CONGRESS 2019

Topic: Leukocytes, Inflammation, Immunity

Session: Immuno-inflammation as therapeutic target in heart failure

Thumbnail

This platform is supported by

logo Novo Nordisk